Role of small heterodimer partner in lipid homeostasis and its potential as a therapeutic target for obesity

Bibliogrraphy

• Lalli E, Sassone‑Corsi P: DAX‑1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 17, 1445–1453 (2003).
   Google Scholar
• Lee YS, Chanda D, Sim JG, Park YY, Choi HS: Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int. Rev. Cytology 261, 117–158 (2007).
   Google Scholar
• Lee HK, Lee YK, Park SH et al.: Structure and expression of the orphan nuclear receptor SHP gene. J. Biol. Chem. 273, 14398–14402 (1998).
   Google Scholar
• Seol W, Choi HS, Moore DD: An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272, 1336–1339 (1996). Original research paper describing the cloning of small heterodimer protein (SHP).
   Google Scholar
• Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf DJ: Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789–799 (2006).
   Google Scholar
• Yang X, Downes M, Yu RT et al.: Nuclear receptor expression links the circadian clock to metabolism. Cell 126, 801–810 (2006).
   Google Scholar
• Johansson L, Bavner A, Thomsen JS, Farnegardh M, Gustafsson JA, Treuter E: The orphan nuclear receptor SHP utilizes conserved LXXLL‑related motifs for interactions with ligand‑activated estrogen receptors. Mol. Cell Biol. 20, 1124–1133 (2000).
   Google Scholar
• Borgius LJ, SteVensen KR, Gustafsson JA, Treuter E: Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP. J. Biol. Chem. 277, 49761–49766 (2002).
   Google Scholar
• Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S: Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry 40, 15369–15377 (2001).
   Google Scholar
• Soel W, Chung M, Moore DD: Novel receptor interaction and repression domains in the orphan receptor SHP. Mol. Cell Biol. 17, 7126–7131 (1997).
   Google Scholar
• Bavner A, Sanyal S, Gustafsson JA, Treuter E: Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol. Metab. 16, 478–488 (2005). Excellent review of the basic transcriptional repression function of SHP.
   Google Scholar
• Xie YB, Lee OH, Nedumaran B et al.: SMILE, a new orphan nuclear receptor SHP‑interacting protein, regulates SHPrepressed estrogen receptor transactivation. Biochem. J. 416, 463–473 (2008).
   Google Scholar
• Suh JH, Huang J, Park YY et al.: Orphan nuclear receptor small heterodimer partner inhibits transforming growth factor‑β signaling by repressing SMAD3 transactivation. J. Biol. Chem. 281, 39169–39178 (2006).
   Google Scholar
• Klinge CM, Jernigan SC, Risinger KE et al.: Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT). Arch. Biochem. Biophys. 390, 64–70 (2001).
   Google Scholar
• Chanda D, Xie YB, Choi HS: Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH‑1 transactivation. Nucleic Acids Res. DOI: 10.1093/nar/gkq227 (2010) (Epub ahead of print).
   Google Scholar
• Ehrlund A, Anthonisen EH, Gustafsson N et al.: E3 ubiquitin ligase RNF31 cooperates with DAX‑1 in transcriptional repression of steroidogenesis. Mol. Cell Biol. 29, 2230–2242 (2009).
   Google Scholar
• Parks RK, Blanchard SG, Bledsoe RK et al.: Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365–1368 (1999).
   Google Scholar
• Goodwin B, Jones SA, Price RR et al.: A regulatory cascade of the nuclear receptors FXR, SHP‑1, and LRH‑1 represses bile acid biosynthesis. Mol. Cell 6, 517–526 (2000). One of the initial studies elucidating the feedback regulatory pathway of bile acid synthesis involving SHP.
   Google Scholar
• Lu TT, Makishima M, Repa JJ et al.: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6, 507–515 (2000). One of the initial studies elucidating the feedback regulatory pathway of bile acid synthesis involving SHP.
   Google Scholar
• Wang L, Lee YK, Bundman D et al.: Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2, 721–731 (2002). One of the first studies using SHP-knockout mice to elucidate the function of SHP in bile acid metabolism.
   Google Scholar
• Kerr TA, Saeki S, Schneider M et al.: Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell 2, 713–720 (2002). One of the first studies using SHP-knockout mice to elucidate the function of SHP in bile acid metabolism.
   Google Scholar
• Li T, Chiang JY: Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 α‑hydroxylase gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G74–G84 (2005).
   Google Scholar
• Li T, Jahan A, Chiang JY: Bile acids and cytokines inhibit the human cholesterol 7 α‑hydroxylase gene via the JNK/c‑jun pathway in human liver cells. Hepatology 43, 1202–1210 (2006).
   Google Scholar
• Inagaki T, Choi M, Moschetta A et al.: Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217–225 (2005).
   Google Scholar
• Watanabe M, Houten SM, Mataki C et al.: Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484–489 (2006).
   Google Scholar
• Hartman HB, Lai K, Evans MJ: Loss of small heterodimer partner expression in the liver protects against dyslipidemia. J. Lipid Res. 50, 193–203 (2009). First study using OB/SHP double knockout
   Google Scholar
• Boulias K, Katrakili N, Bamberg K, Underhill P, Greenfield A, Talianidis I: Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP. EMBO J. 24, 2624–2633 (2005). First study using LDLR/SHP double knockout and liver-specific SHP-knockout mice to demonstrate that loss of SHP protected against hypercholesterolemia.
   Google Scholar
• Matsukuma KE, Wang L, Bennett MK, Osborne TF: A key role for orphan nuclear receptor liver receptor homologue‑1 in activation of fatty acid synthase promoter by liver X receptor. J. Biol. Chem. 282, 20164–20171 (2007).
   Google Scholar
• Watanabe M, Houten SM, Wang L et al.: Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP‑1c. J. Clin. Invest. 113, 1408–1418 (2004).
   Google Scholar
• Huang J, Iqbal J, Saha PK et al.: Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver. Hepatology 46, 147–157 (2007). First study using liver-specific SHP overexpression in mice showing increased fat accumulation in the liver.
   Google Scholar
• Delerive P, Galardi CM, Bisi JE, Nicodeme E, Goodwin B: Identification of liver receptor homolog‑1 as a novel regulator of apolipoprotein A1 gene transcription. Mol. Endocrinol. 18, 2378–2387 (2004).
   Google Scholar
• Wang L, Han Y, Kim CS, Lee YK, Moore DD: Resistance of SHP‑null mice to bile acid‑induced liver damage. J. Biol. Chem. 278, 44475–44481 (2003).
   Google Scholar
• Wang L, Liu J, Saha P et al.: The orphan nuclear receptor SHP regulates PGC‑1α expression and energy production in brown adipocytes. Cell Metab. 2, 227–238 (2005). First study demonstrating that SHP gene
   Google Scholar
• Nishigori H, Tomura H, Tonooka N et al.: Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc. Natl. Acad. Sci. USA 98, 575–580 (2001).
   Google Scholar
• Enya M, Horikawa Y, Kuroda E et al.: Mutations in the small heterodimer partner gene increase morbidity risk in Japanese Type 2 diabetes patients. Hum. Mutat. 29, E271–E277 (2008).
   Google Scholar
• Hung CC, Farooqi IS, Ong K et al.: Contribution of variants in the small heterodimer partner gene to birth weight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations. Diabetes 52, 1288–1291 (2003).
   Google Scholar
• Mitchell SM, Weedon MN, Owen KR et al.: Genetic variation in the small heterodimer partner gene and young‑onset Type 2 diabetes, obesity, and birth weight in UK subjects. Diabetes 52, 1276–1279 (2003). mice to demonstrate that SHP gene deletion in leptin-deficient mice prevented the development of fatty liver and improved insulin sensitivity.
   Google Scholar
• Echwald SM, Andersen KL, Sørensen TI et al.: Mutation analysis of NR0B2 among 1545 Danish men identifies a novel c.278G>A (p.G93D) variant with reduced functional activity. Hum. Mutat. 24, 381–387 (2004).
   Google Scholar
• Stuart JA, Cadenas S, Jekabsons MB, Roussel D, Brand MD: Mitochondrial proton leak and the uncoupling protein 1 homologues. Biochim. Biophys. Acta 1504, 144–158 (2001).
   Google Scholar
• Song G, Park K, Wang L: Gene expression profiling reveals a diverse array of pathways inhibited by nuclear receptor SHP during adipogenesis. Int. J. Clin. Exp. Pathol. 2, 275–285 (2009). deletion prevented the development of obesity in mice.
   Google Scholar
• Tabbi‑Anneni I, Cooksey R, Gunda V et al.: Overexpression of nuclear receptor SHP in adipose tissues affects diet induced obesity and adaptive thermogenesis. Am. J. Physiol. Endocrinol. Metab. 298, E961–E970 (2010). 98, 575–580 (2001). First study linking SHP genetic variations to increased bodyweight in humans.
   Google Scholar